The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Mechanisms of antidiabetic effects of flavonoid rutin
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It also has antidiabetic and anti-inflammatory properties, thus preventing diabetes-related pathologies [37,38].”
From Health Benefits and Chemical Composition of Matcha Green Tea: A Review (2020) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Tzoulaki, I., Molokhia, M., Curcin, V., Little, M. P., Millett, C. J., Ng, A., Hughes, R. I., Khunti, K., Wilkins, M. R., Majeed, A., et al. (2009) · BMJ · doi:10.1136/bmj.b4731 · Cited by 444
Research works printed but not linked: 78
- Lotfy, 2017, Chronic complications of diabetes mellitus: a mini review, Curr. Diabetes Rev., 13, 3, 10.2174/1573399812666151016101622 · DOI · Paper page
- Vinayagam, 2015, Antidiabetic properties of dietary flavonoids: a cellular mechanism review, Nutr. Metab., 12, 60, 10.1186/s12986-015-0057-7 · DOI · Paper page
- Gullón, 2017, Rutin A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability, Trends Food Sci. Technol., 67, 220, 10.1016/j.tifs.2017.07.008 · DOI · Paper page
- Selloum, 2003, Anti-inflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation, Exp. Toxicol. Pathol., 54, 313, 10.1078/0940-2993-00260 · DOI · Paper page
- Yang, 2008, In vitro antioxidant properties of rutin, LWT-Food Sci. Technol., 41, 1060, 10.1016/j.lwt.2007.06.010 · DOI · Paper page
- Alinejad, 2013, Effects of combinations of curcumin, linalool, rutin, safranal, and thymoquinone on glucose/serum deprivation-induced cell death, Avicenna J. Phytomed., 3, 321
- Sadeghnia, 2013, Protective effect of rutin on hexachlorobutadiene-induced nephrotoxicity, Renal Fail., 35, 1151, 10.3109/0886022X.2013.815546 · DOI
- Janbaz, 2002, Protective effect of rutin on paracetamol-and CCl 4-induced hepatotoxicity in rodents, Fitoterapia, 73, 557, 10.1016/S0367-326X(02)00217-4 · DOI · Paper page
- Niture, 2014, Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers, Ind. J. Exp. Biol., 52, 720
- Prince, 2006, Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes, J. Biochem. Mol. Toxicol., 20, 96, 10.1002/jbt.20117 · DOI · Paper page
- Kamalakkannan, 2006, Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues, Mol. Cell. Biochem., 293, 211, 10.1007/s11010-006-9244-1 · DOI · Paper page
- Prince, 2006, Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats, J. Pharm. Pharmacol., 58, 1373, 10.1211/jpp.58.10.0011 · DOI
- Alsaif, 2009, Beneficial effects of rutin and vitamin C coadministration in a streptozotocin-induced diabetes rat model of kidney nephrotoxicity, Pak. J. Nutr., 8, 745, 10.3923/pjn.2009.745.754 · DOI
- Ola, 2015, Neuroprotective effects of rutin in streptozotocin-induced diabetic rat retina, J. Mol. Neurosci., 56, 440, 10.1007/s12031-015-0561-2 · DOI
- Al-Enazi, 2014, Protective effects of combined therapy of Rutin with Silymarin on experimentally-induced diabetic neuropathy in rats, Pharmacol. Pharm., 5, 876, 10.4236/pp.2014.59098 · DOI
- Saklani, 2016, Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats, Mol. Cell. Biochem., 420, 65, 10.1007/s11010-016-2767-1 · DOI
- Fernandes, 2010, Influence of rutin treatment on biochemical alterations in experimental diabetes, Biomed. Pharmacother., 64, 214, 10.1016/j.biopha.2009.08.007 · DOI · Paper page
- Tian, 2016, Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats, Eur. J. Pharmacol., 771, 84, 10.1016/j.ejphar.2015.12.021 · DOI
- Guimaraes, 2015, Rutin administration attenuates myocardial dysfunction in diabetic rats, Cardiovasc. Diabetol., 14, 90, 10.1186/s12933-015-0255-7 · DOI
- Wang, 2015, Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes, Exp. Ther. Med., 9, 451, 10.3892/etm.2014.2090 · DOI
- Akondi, 2011, Protective effect of Rutin and Naringin on sperm quality in streptozotocin (STZ) induced type 1 diabetic rats, Iran. J. Pharm. Res., 10, 585
- Hao, 2012, Preventive effects of rutin on the development of experimental diabetic nephropathy in rats, Life Sci., 91, 959, 10.1016/j.lfs.2012.09.003 · DOI
- Chu, 2010, Protective effect of rutin from buckwheat flowers and leaves on hepatic injury at early stage in diabetic rats, Jiangsu Med. J., 8, 026
- Gao, 2015, Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin, Exp. Ther. Med., 9, 1103, 10.3892/etm.2015.2223 · doi:10.3892/etm.2015.2223
- Bais, 2017, Evaluation of effect of rutin in diabetes rat gastropathy, Int. J. Pharm. Phytopharmacol. Res., 1, 363
- Jadhav, 2012, Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin-nicotinamide induced type 2 diabetic rats, Int. J. Pharm. Pharm. Sci., 4, 251
- Hunyadi, 2012, Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats, PLoS One, 7, e50619, 10.1371/journal.pone.0050619 · DOI · Paper page
- Hsu, 2014, Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation, Mol. Nutr. Food Res., 58, 1168, 10.1002/mnfr.201300691 · DOI
- Srinivasan, 2005, Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice, Ind. J. Pharmacol., 37, 327, 10.4103/0253-7613.16859 · doi:10.4103/0253-7613.16859
- Dake, 2016, Diabetic dyslipidemia review: an update on current concepts and management guidelines of diabetic dyslipidemia, Am. J. Med. Sci., 351, 361, 10.1016/j.amjms.2016.01.020 · DOI
- Ghorbani, 2014, Clinical and experimental studies on polyherbal formulations for diabetes: current status and future prospective, J. Integr. Med., 12, 336, 10.1016/S2095-4964(14)60031-5 · DOI
- Ghorbani, 2013, Best herbs for managing diabetes: a review of clinical studies, Braz. J. Pharm. Sci., 49, 413, 10.1590/S1984-82502013000300003 · DOI
- Ghorbani, 2013, Phytotherapy for diabetic dyslipidemia: evidence from clinical trials, Clin. Lipidol., 8, 311, 10.2217/clp.13.26 · DOI
- Ahmed, 2010, Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats, Diabetol. Croat., 39, 15
- Sattanathan, 2011, Beneficial health effects of rutin supplementation in patients with diabetes mellitus, J. Appl. Pharm. Sci., 1, 227
- Li, 2009, Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase, J. Agric. Food Chem., 57, 11463, 10.1021/jf903083h · DOI · Paper page
- Jo, 2009, Comparison of antioxidant potential and rat intestinal α-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin, Int. J. Appl. Res. Nat. Prod., 2, 52
- Esmaeili, 2009, Antioxidant and protective effects of major flavonoids from Teucrium polium on β-cell destruction in a model of streptozotocin-induced diabetes, Planta Med., 75, 1418, 10.1055/s-0029-1185704 · doi:10.1055/s-0029-1185704
- Cai, 2009, Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells, J. Agric. Food Chem., 57, 9817, 10.1021/jf902618v · DOI · Paper page
- Kappel, 2013, Involvement of GLUT-4 in the stimulatory effect of rutin on glucose uptake in rat soleus muscle, J. Pharm. Pharmacol., 65, 1179, 10.1111/jphp.12066 · DOI
- Khan, 2002, Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways, Diabetologia, 45, 1475, 10.1007/s00125-002-0974-7 · DOI · Paper page
- Boden, 2001, Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus, Am. J. Physiol. Endocrinol. Metab., 280, E23, 10.1152/ajpendo.2001.280.1.E23 · DOI · Paper page
- Barthel, 2003, Novel concepts in insulin regulation of hepatic gluconeogenesis, Am. J. Physiol. Endocrinol. Metab., 285, E685, 10.1152/ajpendo.00253.2003 · DOI · Paper page
- Hosseini, 2015, Pancreatic beta cell protection/regeneration with phytotherapy, Braz. J. Pharm. Sci., 51, 1, 10.1590/S1984-82502015000100001 · DOI
- Brownlee, 2005, The pathobiology of diabetic complications, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615 · DOI · Paper page
- Singh, 2014, Advanced glycation end products and diabetic complications, Korean J. Physiol. Pharm., 18, 1, 10.4196/kjpp.2014.18.1.1 · DOI · Paper page
- Vetter, 2015, Glycated serum albumin and AGE receptors, Adv. Clin. Chem., 72, 205, 10.1016/bs.acc.2015.07.005 · DOI
- Nagasawa, 2003, Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative, Mol. Cell. Biochem., 249, 3, 10.1023/A:1024793429244 · DOI
- Laurean, 2007, Rutin derivatives as potent AGE inhibitors and its relevance in diabetes complications, FASEB J., 21, A633, 10.1096/fasebj.21.5.A633-a · doi:10.1096/fasebj.21.5.a633-a
- Muthenna, 2012, Inhibition of advanced glycation end-product formation on eye lens protein by rutin, Br. J. Nutr., 107, 941, 10.1017/S0007114511004077 · DOI
- Nagasawa, 2003, Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats, Mol. Cell. Biochem., 252, 141, 10.1023/A:1025563519088 · DOI
- Kamalakkannan, 2006, The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney, J. Pharm. Pharmacol., 58, 1091, 10.1211/jpp.58.8.0010 · DOI
- Geraldes, 2010, Activation of protein kinase C isoforms and its impact on diabetic complications, Circ. Res., 106, 1319, 10.1161/CIRCRESAHA.110.217117 · DOI · Paper page
- Reddy, 2011, Inhibition of aldose reductase and sorbitol accumulation by dietary rutin, Curr. Sci., 101, 1191
- Cao, 1997, Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships, Free Radical Biol. Med., 22, 749, 10.1016/S0891-5849(96)00351-6 · DOI · Paper page
- Ghiasi, 2011, Quantum mechanical study of antioxidative ability and antioxidative mechanism of rutin (vitamin P) in solution, Carbohydr. Res., 346, 739, 10.1016/j.carres.2011.01.021 · doi:10.1016/j.carres.2011.01.021
- Das, 2016, Polyphenol compounds and PKC signaling, Biochem. Biophys. Acta, 1860, 2107, 10.1016/j.bbagen.2016.06.022 · DOI
- Ferriola, 1989, Protein kinase C inhibition by plant flavonoids: kinetic mechanisms and structure-activity relationships, Biochem. Pharmacol., 38, 1617, 10.1016/0006-2952(89)90309-2 · DOI · Paper page
- End, 1987, Non-selective inhibition of mammalian protein kinases by flavinoids in vitro, Res. Commun. Chem. Pathol. Pharmacol., 56, 75
- Sprague, 2009, Inflammatory cytokines in vascular dysfunction and vascular disease, Biochem. Pharmacol., 78, 539, 10.1016/j.bcp.2009.04.029 · DOI · Paper page
- Dronavalli, 2008, The pathogenesis of diabetic nephropathy, Nat. Rev. Endocrinol., 4, 444, 10.1038/ncpendmet0894 · DOI · Paper page
- Schena, 2005, Pathogenetic mechanisms of diabetic nephropathy, J. Am. Soc. Nephrol., 16, S30, 10.1681/ASN.2004110970 · DOI · Paper page
- Hu, 2009, Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement, Am. J. Physiol. Renal Physiol., 297, F1080, 10.1152/ajprenal.90767.2008 · DOI
- Rauter, 2010, Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats, Phytother. Res., 24, 10.1002/ptr.3017 · DOI
- Xu, 2014, A glimpse of matrix metalloproteinases in diabetic nephropathy, Curr. Med. Chem., 21, 3244, 10.2174/0929867321666140716092052 · DOI
- Pu, 2007, Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats, J. Pharmacol. Sci., 104, 329, 10.1254/jphs.FP0070247 · DOI · Paper page
- Amarapurkar, 2002, Chronic liver disease in diabetes mellitus, Trop. Gastroenterol., 23, 3
- Harrison, 2006, Liver disease in patients with diabetes mellitus, J. Clin. Gastroenterol., 40, 68, 10.1097/01.mcg.0000190774.91875.d2 · DOI · Paper page
- Arkkila, 2001, Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes, Diabetes Res. Clin. Pract., 52, 113, 10.1016/S0168-8227(00)00241-2 · doi:10.1016/s0168-8227(00)00241-2
- Lucchesi, 2013, Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease, Acta Cir. Bras., 28, 502, 10.1590/S0102-86502013000700005 · DOI
- Kakkar, 1998, Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes, Clin. Sci., 94, 623, 10.1042/cs0940623 · DOI · Paper page
- Stolar, 2003, Type 2 diabetes cardiovascular risk, and the link to insulin resistance, Clin. Ther., 25, B4, 10.1016/S0149-2918(03)80240-0 · DOI
- Shah, 2016, Molecular and cellular mechanisms of cardiovascular disorders in diabetes, Circ. Res., 118, 1808, 10.1161/CIRCRESAHA.116.306923 · DOI · Paper page
- Krishna, 2005, Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats, Can. J. Physiol. Pharmacol., 83, 343, 10.1139/y05-009 · DOI
- Challa, 2011, Partial role of nitric oxide in infarct size limiting effect of quercetin and rutin against ischemia-reperfusion injury in normal and diabetic rats, Ind. J. Exp. Biol., 49, 207
- Annapurna, 2009, Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats, J. Pharm. Pharmacol., 61, 1365, 10.1211/jpp.61.10.0014 · DOI
- Graefe, 1999, Relative systemic availability of the flavonoids quercetin and rutin in humans, Arch. Pharm. Pharm. Med. Chem., 332, 20
- Al-Roujeaie, 2016, Effect of rutin on diabetic-induced erectile dysfunction: possible involvement of testicular biomarkers in male rats, Andrologia, 1
Cited by
Rudrapal, M., Khairnar, S. J., Khan, J., Dukhyil, A. B., Ansari, M. A., Alomary, M. N., Alshabrmi, F. M., Palai, S., Deb, P. K., & Devi, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.806470 · Cited by 1,084
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 452
Health Benefits and Chemical Composition of Matcha Green Tea: A Review
Kochman, J., Jakubczyk, K., Antoniewicz, J., Mruk, H., & Janda, K. (2020) · Molecules · doi:10.3390/molecules26010085 · Cited by 328
Meng, Q., Qi, X., Fu, Y., Chen, Q., Cheng, P., Yu, X., Sun, X., Wu, J., Li, W., Zhang, Q., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112326 · Cited by 145
Son, Y., Lee, H., Son, S.-Y., Lee, C.-H., Kim, S.-Y., & Lim, Y. (2021) · Antioxidants · doi:10.3390/antiox10101546 · Cited by 35
Metadata
- Authors
- Ghorbani, A.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 96
- Pages
- 305-312
- ISSN
- 0753-3322
- Cited by
- 511
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Vice Chancellery for Research and Technology, Mashhad University of Medical Sciences, Mashhad, Iran
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of antidiabetic effects of flavonoid rutin. https://app.cochat.ai/papers/10.1016/j.biopha.2017.10.001
- The paper
- Ghorbani, A. (2017). Mechanisms of antidiabetic effects of flavonoid rutin. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2017.10.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.